A Pilot Study of Differences in Antibody Responses of Intradermal and Intramuscular Injections of Botulinum Toxin Type A

Abstract Introduction Botulinum toxin type A (BoNT/A) is commonly used for both medical and aesthetic purposes. However, approximately 3% of long-term recipients develop resistance, potentially due to antibody formation. Injection technique may influence immunogenicity, yet comparative data remain l...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Yuttana Srinoulprasert, Surachet Sirisuthivoranunt, Chattip Sripatumtong, Tunsuda Tansit, Chadakan Yan, Chalermkwan Apinuntham, Thanya Techapichetvanich, Sasima Eimpunth, Woraphong Manuskiatti, Rungsima Wanitphakdeedecha
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Adis, Springer Healthcare 2025-09-01
Saila:	Dermatology and Therapy
Gaiak:	Botulinum toxin type A Route of injection Neutralizing antibody Complexing protein
Sarrera elektronikoa:	https://doi.org/10.1007/s13555-025-01530-y
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!